IDEXX Laboratories, Inc.
IDXX
$658.06
$8.001.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.11B | 998.43M | 954.29M | 975.54M | 1.00B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.11B | 998.43M | 954.29M | 975.54M | 1.00B |
| Cost of Revenue | 414.73M | 375.05M | 383.63M | 379.51M | 384.42M |
| Gross Profit | 694.73M | 623.38M | 570.66M | 596.04M | 619.16M |
| SG&A Expenses | 259.79M | 247.78M | 251.25M | 176.67M | 238.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 736.41M | 681.89M | 692.60M | 610.15M | 678.28M |
| Operating Income | 373.05M | 316.53M | 261.69M | 365.39M | 325.30M |
| Income Before Tax | 362.35M | 310.08M | 256.39M | 298.91M | 259.06M |
| Income Tax Expenses | 68.36M | 67.41M | 40.24M | 66.07M | 55.76M |
| Earnings from Continuing Operations | 293.99M | 242.68M | 216.15M | 232.84M | 203.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 293.99M | 242.68M | 216.15M | 232.84M | 203.30M |
| EBIT | 373.05M | 316.53M | 261.69M | 365.39M | 325.30M |
| EBITDA | 408.82M | 350.60M | 295.39M | 399.53M | 357.49M |
| EPS Basic | 3.66 | 2.98 | 2.64 | 2.83 | 2.46 |
| Normalized Basic EPS | 2.82 | 2.38 | 1.96 | 2.74 | 2.42 |
| EPS Diluted | 3.63 | 2.96 | 2.62 | 2.80 | 2.44 |
| Normalized Diluted EPS | 2.80 | 2.37 | 1.94 | 2.71 | 2.40 |
| Average Basic Shares Outstanding | 80.41M | 81.32M | 81.85M | 82.30M | 82.63M |
| Average Diluted Shares Outstanding | 80.99M | 81.92M | 82.54M | 83.06M | 83.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |